stockportfolio.pro
Stocks / MGTX vs TBPH
MGTX vs TBPH
MeiraGTx Holdings plc and Theravance Biopharma, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| MeiraGTx Holdings plc (MGTX) | Theravance Biopharma, Inc. (TBPH) | |
|---|---|---|
| Market cap | $0.9B | $0.8B |
| Revenue (latest FY) | $81.39M | $107.46M |
| Net income (latest FY) | $-114.20M | $105.89M |
| Revenue growth (5y CAGR) | 39.2% | 8.4% |
| Net margin | -140.3% | 98.5% |
| Return on equity | 1971.4% | 35.7% |
| P/E ratio | — | 7.4 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 2 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open MGTX — free Open TBPH — freeFrequently asked questions
Which is bigger, MGTX or TBPH?
MeiraGTx Holdings plc is larger by market capitalization — $0.9B versus $0.8B.
Which grows faster, MGTX or TBPH?
Over the last five fiscal years, MeiraGTx Holdings plc grew revenue faster — 39.2%/yr versus 8.4%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.